Emerson Clinical Research Institute - Washington - Connecticut Avenue — Washington D.C., District of Columbia

Emerson Clinical Research Institute - Washington - Connecticut Avenue is a clinical research site located in Washington D.C., District of Columbia, United States 20009.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Emerson Clinical Research Institute - Washington - Connecticut Avenue has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Sponsors: BioNTech SE, Pfizer.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emerson Clinical Research Institute - Washington - Connecticut Avenue?

Emerson Clinical Research Institute - Washington - Connecticut Avenue has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emerson Clinical Research Institute - Washington - Connecticut Avenue conducted?

Emerson Clinical Research Institute - Washington - Connecticut Avenue has 3 clinical trials on record, with 1 currently active. Their work covers SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Is Emerson Clinical Research Institute - Washington - Connecticut Avenue accredited by Crixeo Health?

Emerson Clinical Research Institute - Washington - Connecticut Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emerson Clinical Research Institute - Washington - Connecticut Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.